Our findings provide novel insight into mechanisms underlying tumor immune evasion and suggest that blocking ANGPTL2 signaling in tumor cells could be a potential strategy to promote tumor elimination by T‐cell‐mediated anti‐tumor immunity. The gene discussed is ANGPTL2; the disease is neoplasm.